Detalhe da pesquisa
1.
Safety and immunogenicity of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120 vaccine boost adjuvanted with MF59 or alum in healthy adults without HIV (HVTN 107): A phase 1/2a randomized trial.
PLoS Med
; 21(3): e1004360, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38502656
2.
Analysis of the HIV Vaccine Trials Network 702 Phase 2b-3 HIV-1 Vaccine Trial in South Africa Assessing RV144 Antibody and T-Cell Correlates of HIV-1 Acquisition Risk.
J Infect Dis
; 226(2): 246-257, 2022 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35758878
3.
Achieving intracellular cytokine staining assay concordance on two continents to assess HIV vaccine-induced T-cell responses.
J Leukoc Biol
; 112(5): 1167-1181, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35866359